dc.creatorCórdoba, Susana
dc.creatorRodero, Laura
dc.creatorVivot, Walter
dc.creatorAbrantes, Ruben Antonio
dc.creatorDavel, Graciela Odelsia
dc.creatorVitale, Roxana G
dc.date2020-12-04T09:08:59Z
dc.date2020-12-04T09:08:59Z
dc.date2008-02
dc.date.accessioned2023-08-29T20:07:31Z
dc.date.available2023-08-29T20:07:31Z
dc.identifier0924-8579
dc.identifierhttp://sgc.anlis.gob.ar/handle/123456789/1818
dc.identifier10.1016/j.ijantimicag.2007.09.005
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8519704
dc.descriptionFil: Córdoba, Susana. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Micología; Argentina.
dc.descriptionFil: Davel, Graciela Odelsia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Micología; Argentina.
dc.descriptionFil: Vivot, Walter. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Micología; Argentina.
dc.descriptionFil: Ruben Abrantes. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Micología; Argentina.
dc.descriptionFil: Laura Rodero. Universidad Católica de Buenos Aires. Facultad de Ciencias Médicas; Argentina.
dc.descriptionFil: Vitale, Roxana G. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Micología; Argentina.
dc.descriptionThe in vitro activities of amphotericin B (AMB), itraconazole (ITC), voriconazole (VCZ) and terbinafine (TBF) alone and in the combinations AMB+VCZ, TBF+ITC and TBF+VCZ were evaluated against 29 clinical isolates of Fusarium spp. (15 Fusarium solani, 7 Fusarium oxysporum, 2 Fusarium decemcellulare, 2 Fusarium dimerum and 3 other Fusarium spp.). Minimum inhibitory concentrations were determined using the method of the Clinical and Laboratory Standards Institute and the interaction activity was calculated using the fractional inhibitory concentration index. The four antifungal drugs tested alone showed very limited activity against most of the isolates. In contrast, the combination TBF+VCZ showed synergy for 21 isolates. The combination AMB+VCZ showed synergism for only five strains. No interaction or antagonism was observed among the remaining strains. TBF+ITC showed no interaction for 18 strains. The in vitro antifungal activity of the drugs alone and in combination varied for different species. These results corroborate previous in vitro studies in which the combination TBF+VCZ showed synergy against Fusarium spp., although further studies are needed to elucidate its potential usefulness for therapy.
dc.formatpdf
dc.languageen
dc.relationInternational journal of antimicrobial agents
dc.rightsnone
dc.sourceInternational journal of antimicrobial agents.2008;31(2):171-174
dc.subjectAnfotericina B
dc.subjectAntifúngicos
dc.subjectInteracciones Farmacológicas
dc.subjectFusarium
dc.subjectHumanos
dc.subjectItraconazol
dc.subjectPruebas de Sensibilidad Microbiana
dc.subjectNaftalenos
dc.subjectPirimidinas
dc.subjectTerbinafina
dc.subjectTriazoles
dc.subjectVoriconazol
dc.titleIn vitro interactions of antifungal agents against clinical isolates of Fusarium spp
dc.typeArtículo


Este ítem pertenece a la siguiente institución